Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (MM)
This study is currently recruiting participants.
Verified October 2017 by AbbVie
First Posted: September 14, 2016
Last Update Posted: November 2, 2017
Onyx Therapeutics, Inc.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 22, 2020|
|Estimated Primary Completion Date:||March 27, 2020 (Final data collection date for primary outcome measure)|